Talk:TranSMART

question
Is TranSMART actually in wide use? What is it's specific relevance? — Preceding unsigned comment added by 212.126.160.103 (talk • contribs) 09:50, 30 January 2018 (UTC)

Eyes
this might need a pair of eyes. Looks to be native advertising by J&J but I'm not as good on medical things. TonyBallioni (talk) 21:09, 16 April 2018 (UTC)
 * I don't see so much as native advertising as advocacy for an open-source software project. We get a lot of that. The author does work for a company that helped build it but this is not a profit-making product.  So more of an advocacy thing.  It needs a bunch of work to source it better and explain it better (I at first thought that the goal was to make the data open like what AllTrials advocates for but this is not that.)  People have their own instances of the databasse.  They can use it to share data, but that is not what it does. It enables sharing in a standardized way, at scale.  I think. I need to read more.  Jytdog (talk) 00:38, 17 April 2018 (UTC)

It's not a J&J project any more and hasn't been for many years. And the author works for a company that's done some work on it - they weren't the creators by a long shot. Is it significant enough to be listed? You'd need something benchmark for what makes software significant. It's widely used in a number of big pharma & biomedical projects. — Preceding unsigned comment added by 165.225.80.240 (talk) 15:31, 11 March 2019 (UTC)